This study investigates the effectiveness of combining two imaging techniques, multiparametric magnetic resonance imaging (mpMRI) and 68Ga-Prostate-specific membrane antigen (PSMA-11) positron emission tomography/computed tomography (PET/CT), to diagnose clinically significant prostate cancer (csPCa). The gene discussed is FOLH1; the disease is prostate carcinoma.